Professional Documents
Culture Documents
A
rtificial intelligence (AI) and other ad- otherwise look like a good solution—e.g., a drug
vanced technologies are raising the stakes that is cheaper and readily available—may not,
on lifelong learning. Employers today in fact, be optimal. For example, a study of anti-
must prepare their workforce for the AI-enabled hypertensive medications (https://www.ncbi.nlm.
world, where people increasingly work along- nih.gov/pmc/articles/PMC4225910/) found that
side machines that augment human capabilities. the most expensive treatment option worked
Business leaders are beginning to recognize that the best, while the cheapest option was the least
the differentiator will not just be the technology, effective. One can imagine how, without such
but also the capability of people to use it. scientific research, doctors might be reluctant to
The demands of the 21st century workforce prescribe a costly blood pressure medicine over
necessitate an equally advanced approach to less expensive options, and payers would most
Ulrik Juul
training and development. Adaptive learning certainly balk at paying for it. Only scientific
Christensen, M.D.,
—a personalized, software-enabled teaching evidence proves the point.
is the executive
approach—has a crucial role in helping learners Similarly, education companies must invest
chairman for Area9 develop new skills and become more proficient the necessary time and money to develop an
Lyceum (https:// on a continuous basis. evidence-based approach to demonstrate effica-
area9lyceum.com) But not all learning technology is created equal. cy of educational tools and interventions, and to
and the former It is no longer enough for learning companies to compare the success rates of different systems.
senior fellow, Digital make unsubstantiated claims about their systems Admittedly, this is not easy and the costs will
Learning, on the and then spend marketing dollars to promote not be inconsequential. Nonetheless, for educa-
executive leadership their solutions. Instead, education companies tion companies to be considered truly scientific
team for McGraw-Hill need to invest in the necessary science to develop in their approach, they must become more sys-
Education. an evidence-based approach for both higher tematic, so educators, schools, and districts can
education and corporate education. Evidence make the best purchasing decisions among the
of efficacy then can become the basis for programs and content being offered.
purchasers of education solutions to make their Education is big business. According to a
buying decisions. Georgetown University study, some $1.1 trillion
is spent annually in the U.S. by postsecond-
LESSONS LEARNED FROM HEALTH CARE ary institutions, government agencies, and
In adopting an evidence-based approach, edu- employers on formal and informal higher edu-
cation can learn a vital lesson from health cation and training (https://cew.georgetown.edu/
care, particularly the pharmaceutical indus- wp-content/uploads/2015/02/Trillion-Dollar-Train-
try. A seismic shift occurred among medical ing-System-.pdf). Of that, employers spend an
researchers in the 1990s, away from heavy re- estimated $413 billion a year on informal train-
liance on peer-reviewed articles that often ing, and another $177 billion on formal training.
were based on anecdotal observations of small Despite these huge dollars, the only common
groups of patients, to a broader standard of measurement among training programs is the
evidence-based medicine (https://muse.jhu.edu/ cost per student. Occasionally, they track job
article/211661). The objective was to define opti- placement rates and even less frequently on-the-
mal treatments and drug therapies using current job retention.
best evidence from a variety of statistical meta- As a recent Harvard Business Review article not-
analyses, including randomized clinical trials. ed, “These metrics are useful but miss the big
Today, the majority of drugs that have health val- picture, in part because they mistake a program’s
ue are used because the pharmaceutical industry cost for its value,” (https://hbr.org/2017/02/a-better-
is being held responsible to secure the research metric-for-the-value-of-a-worker-training-program).
that generates the science around them. Clearly, the time has come for providers of high-
Such research is crucial because what might er education and corporate education to take an